TMO Thermo Fisher Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TMO

Price (delayed)

$520.14

Market cap

$200.63B

P/E Ratio

33.69

Dividend/share

$1.25

EPS

$15.44

Enterprise value

$232.4B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
Thermo Fisher Scientific's revenue has increased by 7% YoY but it has decreased by 2.5% from the previous quarter
The company's equity fell by 3.9% QoQ but it rose by 3.2% YoY
Thermo Fisher Scientific's quick ratio has decreased by 27% from the previous quarter and by 18% YoY
Thermo Fisher Scientific's net income has decreased by 21% YoY and by 13% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.thermofisher.com/
Peers: BDX WAT BIO ISRG

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
385.72M
Market cap
$200.63B
Enterprise value
$232.4B
Valuations
Price to earnings (P/E)
33.69
Price to book (P/B)
4.74
Price to sales (P/S)
4.58
EV/EBIT
31.57
EV/EBITDA
21.63
EV/Sales
5.31
Earnings
Revenue
$43.81B
EBIT
$7.36B
EBITDA
$10.74B
Free cash flow
$5.65B
Per share
EPS
$15.44
Free cash flow per share
$14.63
Book value per share
$109.64
Revenue per share
$113.49
TBVPS
$86.91
Balance sheet
Total assets
$94.66B
Total liabilities
$52.35B
Debt
$35.26B
Equity
$42.26B
Working capital
$4.33B
Liquidity
Debt to equity
0.83
Current ratio
1.27
Quick ratio
0.72
Net debt/EBITDA
2.96
Margins
EBITDA margin
24.5%
Gross margin
40.3%
Net margin
13.8%
Operating margin
16.3%
Efficiency
Return on assets
6.5%
Return on equity
14%
Return on invested capital
15.3%
Return on capital employed
9.3%
Return on sales
16.8%
Dividend
Dividend yield
0.24%
DPS
$1.25
Payout ratio
8.1%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
0.15%
1 week
-0.36%
1 month
-4.35%
1 year
-8.76%
YTD
-5.55%
QTD
-9.76%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$43.81B
Gross profit
$17.65B
Operating income
$7.14B
Net income
$6.02B
Gross margin
40.3%
Net margin
13.8%
Thermo Fisher Scientific's operating margin has decreased by 32% YoY and by 13% from the previous quarter
The operating income has contracted by 27% YoY and by 15% from the previous quarter
The net margin has decreased by 25% YoY and by 11% QoQ
Thermo Fisher Scientific's net income has decreased by 21% YoY and by 13% from the previous quarter

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
TMO P/E details
P/E
33.69
P/B
4.74
P/S
4.58
EV/EBIT
31.57
EV/EBITDA
21.63
EV/Sales
5.31
TMO's EPS is down by 20% year-on-year and by 13% since the previous quarter
The stock's price to earnings (P/E) is 7% more than its last 4 quarters average of 31.4 and 6% more than its 5-year quarterly average of 31.6
The P/B is 5% below the last 4 quarters average of 5.0
The company's equity fell by 3.9% QoQ but it rose by 3.2% YoY
The P/S is 8% below the 5-year quarterly average of 5.0 and 7% below the last 4 quarters average of 4.9
Thermo Fisher Scientific's revenue has increased by 7% YoY but it has decreased by 2.5% from the previous quarter

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital is down by 29% year-on-year and by 12% since the previous quarter
TMO's ROA is down by 29% YoY and by 13% from the previous quarter
The ROE has contracted by 27% YoY and by 14% from the previous quarter
TMO's ROS is down by 24% year-on-year and by 10% since the previous quarter

Dividends

What is TMO's dividend history
Dividend details
DPS
$1.25
Dividend yield
0.24%
Payout ratio
8.1%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 81% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has decreased by 27% from the previous quarter and by 18% YoY
The current ratio has declined by 19% year-on-year and by 14% since the previous quarter
The debt is 17% lower than the equity
Thermo Fisher Scientific's debt to equity has increased by 6% QoQ and by 2.5% YoY
The debt has increased by 6% YoY and by 2.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.